ANDA 88072, held by Epic Pharma LLC. Quinidine Sulfate.
As of Nov 16, 2026, ANDA 88072 (Quinidine Sulfate), held by Epic Pharma LLC, was first approved by FDA on Sep 26, 1983, with 10 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE Conversion of Atrial Fibrillation/Flutter In patients with symptomatic atrial fibrillation/flutter whose symptoms are not adequately controlled by measures that reduce the rate of ventricular response, quinidine sulfate is indicated as a means of restoring normal sinus rhythm. If this use of quinidine sulfate does not restore sinus rhythm within a reasonable time (see DOSAGE AND ADMINISTRATION ), then quinidine sulfate should be discontinued.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 26, 1983 | Original application | Approved | None posted |
| Quinidine Sulfate300MG · tablet;oral | Quinidine Sulfate | Rx |
| Quinidine Sulfate200MG · tablet;oral | Quinidine Sulfate | Rx |
| Feb 10, 2022 | Supplement 18Manufacturing | Approved | None posted |
| Feb 2, 2000 | Supplement 13Manufacturing | Approved | None posted |
| Feb 18, 1999 | Supplement 12Labeling | Approved | None posted |
| Sep 3, 1996 | Supplement 11Labeling | Approved | None posted |
| Nov 8, 1994 | Supplement 8Manufacturing | Approved | None posted |
| Nov 8, 1994 | Supplement 9Manufacturing | Approved | None posted |
| Oct 29, 1992 | Supplement 10Labeling | Approved | None posted |
| Jun 16, 1989 | Supplement 7Labeling | Approved | None posted |
| Feb 7, 1989 | Supplement 6Manufacturing | Approved | None posted |
| May 13, 1985 | Supplement 2Manufacturing | Approved | None posted |
| Sep 26, 1983 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters